MedPath

Acetazolamide

Generic Name
Acetazolamide
Drug Type
Small Molecule
Chemical Formula
C4H6N4O3S2
CAS Number
59-66-5
Unique Ingredient Identifier
O3FX965V0I
Background

One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Indication

For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma

Associated Conditions
Acute angle-closure glaucoma, Edema, Familial periodic paralysis, Generalized Tonic-Clonic Seizures, Metabolic Alkalosis, Open Angle Glaucoma (OAG), Other and unspecified effects of high altitude, Cystine renal calculi, Drug-induced edema, Nonuveitic secondary glaucoma, Salicylate intoxication
Associated Therapies
Urine alkalinization therapy

Acetazolamide for Treating NPH in Shunt-candidates Patients

Phase 2
Conditions
Normal Pressure Hydrocephalus
Interventions
First Posted Date
2018-12-19
Last Posted Date
2018-12-19
Lead Sponsor
Rabin Medical Center
Target Recruit Count
15
Registration Number
NCT03779594
Locations
🇮🇱

Rabin Medical Center, Petah Tikva, Israel

Acetazolamide in Patients With Acute Heart Failure

Phase 3
Conditions
Heart Failure
Acute Heart Failure
Interventions
Drug: Placebo
First Posted Date
2018-10-25
Last Posted Date
2018-10-30
Lead Sponsor
University of Sao Paulo General Hospital
Target Recruit Count
90
Registration Number
NCT03720288
Locations
🇧🇷

Instituto do Coração - HMFMUSP, São Paulo, Brazil

Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia

Completed
Conditions
Sickle Cell Disease
Thalassemia
Healthy Controls
Interventions
First Posted Date
2018-10-23
Last Posted Date
2024-10-30
Lead Sponsor
Children's Hospital Los Angeles
Target Recruit Count
165
Registration Number
NCT03715972
Locations
🇺🇸

CHLA, Los Angeles, California, United States

Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years

Phase 4
Completed
Conditions
Acute Mountain Sickness
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-06-19
Last Posted Date
2021-05-13
Lead Sponsor
University of Zurich
Target Recruit Count
349
Registration Number
NCT03561675
Locations
🇰🇬

National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Effect of Acetazolamide on Lung Water Content by Ultrasound in Patients With Respiratory Disease at Altitude

Phase 4
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-05-30
Last Posted Date
2021-11-05
Lead Sponsor
University of Zurich
Target Recruit Count
112
Registration Number
NCT03540901
Locations
🇰🇬

National Center of Cardiology and Internal Medicine, Biskek, Kyrgyzstan

Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders Older Than 40 Years at Altitude.

Phase 4
Active, not recruiting
Conditions
Altitude Hypoxia
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-05-30
Last Posted Date
2023-03-10
Lead Sponsor
University of Zurich
Target Recruit Count
400
Registration Number
NCT03540914
Locations
🇰🇬

National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at Altitude

Phase 4
Active, not recruiting
Conditions
Altitude Hypoxia
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-05-29
Last Posted Date
2022-11-02
Lead Sponsor
University of Zurich
Target Recruit Count
100
Registration Number
NCT03539367
Locations
🇰🇬

National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Effect of Acetazolamide on Right Heart Function During Exercise in Lowlanders Older Than 40 Years at Altitude

Phase 4
Active, not recruiting
Conditions
Altitude Hypoxia
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-05-25
Last Posted Date
2022-11-02
Lead Sponsor
University of Zurich
Target Recruit Count
100
Registration Number
NCT03537924
Locations
🇰🇬

National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Effect of Acetazolamide on Visuo-motor Learning in Lowlanders Older Than 40 Years at Altitude

Phase 4
Completed
Conditions
Altitude Hypoxia
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-05-24
Last Posted Date
2021-10-12
Lead Sponsor
University of Zurich
Target Recruit Count
59
Registration Number
NCT03536520
Locations
🇰🇬

National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Effect of Acetazolamide on Sleep Disordered Breathing in Lowlanders Older Than 40 Years at Altitude

Phase 4
Completed
Conditions
Altitude Hypoxia
Interventions
Drug: Placebo oral capsule
First Posted Date
2018-05-24
Last Posted Date
2021-11-05
Lead Sponsor
University of Zurich
Target Recruit Count
185
Registration Number
NCT03536507
Locations
🇰🇬

National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

© Copyright 2025. All Rights Reserved by MedPath